ArticleBMC research notes2015
Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland.
Article in BMC research notes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.BMC pharmacology & toxicology · 2017Trial
- Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: Findings from the Irish longitudinal study on ageing (TILDA) in 2016.Exploratory research in clinical and social pharmacy · 2025Article
- Factors facilitating and hindering counselling about generic substitution and a reference price system in community pharmacies - a survey among Finnish dispensers.BMC health services research · 2022Article
- Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.Clinical and translational science · 2020Article
- Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland.BMC health services research · 2020Article
- The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers.BMC health services research · 2019Article
- Regulation of biosimilar medicines and current perspectives on interchangeability and policy.European journal of clinical pharmacology · 2019Review
- Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study.BMC health services research · 2017Observational
- "No generics, Doctor!" The perspective of general practitioners in two French regions.BMC health services research · 2017Observational
- Generic substitution of antiretrovirals: patients' and health care providers' opinions.International journal of STD & AIDS · 2017Observational
- Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients.Journal of clinical and diagnostic research : JCDR · 2017Review
- A study to investigate the factors that influence the prescribing habits of non-consultant hospital doctors in Ireland.Irish journal of medical science · 2017Article
- Pharmacists' views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study.Implementation science : IS · 2017Article
- Evaluation of the effects of a generic substitution policy implemented in Chile.BMJ global health · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Health (Pricing and Supply of Medical Goods) Act 2013 passed into law in July 2013 and legislated for generic substitution in Ireland. The aim of the study was to ascertain the knowledge and perceptions of stakeholders i.e. patients, pharmacists and prescribers, of generic medicines and to generic substitution with the passing of legislation.
methodsThree stakeholder specific questionnaires were developed to assess knowledge of and perceptions to generic medicines and generic substitution. Purposive samples of patients, prescribers and pharmacists were analysed. Descriptive quantitative and qualitative analyses were undertaken. RESULTS AND DISCUSSION: A total of 762 healthcare professionals and 353 patients were recruited. The study highlighted that over 84% of patients were familiar with generic medicines and are supportive of the concept of generic substitution. Approximately 74% of prescribers and 84% of pharmacists were supportive of generic substitution in most cases. The main areas of concern highlighted by the healthcare professionals that might impact on the successful implementation of the policy, were the issue of bioequivalence with generic medicines, the computer software systems used at present in general practitioner (GP) surgeries and the availability of branded generics. The findings from this study identify a high baseline rate of acceptance to generic medicines and generic substitution among patients, prescribers and pharmacists in the Irish setting. The concerns of the main stakeholders provide a valuable insight into the potential difficulties that may arise in its implementation, and the need for on-going reassurance and proactive dissemination of the impact of the generic substitution policy.
conclusionThe existing positive attitude to generic medicines and generic substitution among key stakeholders in Ireland to generic substitution, combined with appropriate support and collaboration should result in the desired increase in rates of prescribing, dispensing and use of generic medicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.